ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01720836
Recruitment Status : Suspended
First Posted : November 2, 2012
Last Update Posted : July 28, 2017
Sponsor:
Information provided by (Responsible Party):
Olivera Finn, University of Pittsburgh

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : February 2019
  Estimated Study Completion Date : February 2022